Gene therapy of liver diseases: A 2011 perspective - 06/12/11
![](/templates/common/images/mail.png)
![](/templates/common/images/entites/204e.gif)
Summary |
Liver diseases including inherited metabolic disorders, chronic viral hepatitis, liver cirrhosis and primary and metastatic liver cancer constitute a formidable health problem because of their high prevalence and the important limitations of current therapies. Gene therapy, a procedure based on the transfer of therapeutic genes to tissues, has been used since the 1990s as a new approach to treating a number of incurable conditions. After a period of lights and shades recent success in treating several devastating diseases like inherited immune deficiency disorders, beta-thalassemia, or inherited blindness appear to herald a new era where gene therapy can be listed among standard therapy options for a wide variety of human conditions. In this review, we provide information illustrating the potentiality of gene therapy in the management of liver diseases lacking other effective therapies.
Il testo completo di questo articolo è disponibile in PDF.Mappa
Vol 35 - N° 11
P. 699-708 - Novembre 2011 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.